NCT05161910View on ClinicalTrials.gov

ROLE OF URINARY BIOMARKER NEUTROPHIL GELATINASE ASSOCIATED LIPOCALCIN (NGAL) IN EARLY PREDICTION OF AKI IN CIRRHOSIS OF LIVER

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

February 1, 2021

Study Completion Date

August 30, 2021

Conditions
Renal Failure
Interventions
OTHER

Biomarkers

Kidney biomarkers appear to be useful in differential diagnosis between acute tubular necrosis (ATN) and other types of acute kidney injury (AKI) in cirrhosis, particularly hepatorenal syndrome (HRS-AKI).

Trial Locations (1)

500082

Asian Institute of Gastroenterology, Hyderabad

All Listed Sponsors
lead

Asian Institute of Gastroenterology, India

OTHER

NCT05161910 - ROLE OF URINARY BIOMARKER NEUTROPHIL GELATINASE ASSOCIATED LIPOCALCIN (NGAL) IN EARLY PREDICTION OF AKI IN CIRRHOSIS OF LIVER | Biotech Hunter | Biotech Hunter